Valerian officinalis l. root extract: no evidence for clinically relevant interactions
- In: Posters E - Natural Products
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PE-003
- By: NIEBER, Karen (University of Leipzig, Institute of Pharmacy, Leipzig, Germany)
- Co-author(s): Hoser, Stefanie (University of Leipzig, Leipzig, Germany)
Michael, Sebastian (L, Waldheim, Germany) - Abstract:
Background: In recent popular publications directed to cancer patients as well as in widely-used patient information websites (e. g. www.cancer.org or www.mskcc.org) valerian is claimed to have a potential of adverse interactions with anti-cancer drugs, thereby questioning its use (1) as a safe replacement for benzodiazepines. Aim: Therefore a..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023